Viridian Therapeutics's total assets for Q3 2025 were $577.14M, a decrease of -0.89% from the previous quarter. VRDN total liabilities were $74.17M for the fiscal quarter, a 10.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.